The therapeutic potential of acetyl-lysine and methyl-lysine effector domains

Drug Discovery Today: Therapeutic Strategies

Volumn 9, Issue 2-3, 2012, Pages

  Brennan, Paul ^a   Filippakopoulos, Panagis ^a   Knapp, Stefan ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL LYSINE; ARGININE; BRM PROTEIN; BROMODOMAIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; HISTONE H3; LYSINE; METHYLLYSINE; PROTEIN; PROTEIN P21; UNCLASSIFIED DRUG;

ACETYLATION; BINDING SITE; DNA DAMAGE; EPIGENETICS; GENETIC TRANSCRIPTION; HISTONE MODIFICATION; MITOSIS; NONHUMAN; POINT MUTATION; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; YEAST;

EID: 84871408488     PISSN: None     EISSN: 17406773     Source Type: Journal    
DOI: 10.1016/j.ddstr.2012.04.001     Document Type: Review

References (72)

1. Choudhary, C. et al. (2009) Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 325, 834-840
2. Bertrand, P. (2010) Inside HDAC with HDAC inhibitors. Eur. J. Med. Chem. 45, 2095-2116
3. Bernstein, B.E. et al. (2007) The mammalian epigenome. Cell 128, 669-681 (Pubitemid 46273573)
4. Herold, J.M. et al. (2011) Small-molecule ligands of methyl-lysine binding proteins. J. Med. Chem. 54, 2504-2511
5. Haynes, S.R. et al. (1992) The bromodomain: a conserved sequence found in human, Drosophila and yeast proteins. Nucleic Acids Res. 20, 2603
6. Kalkhoven, E. (2004) CBP and p300: HATs for different occasions. Biochem. Pharmacol. 68, 1145-1155 (Pubitemid 39094280)
7. Nakamura, T. et al. (2000) huASH1 protein, a putative transcription factor encoded by a human homologue of the Drosophila ash1 gene, localizes to both nuclei and cell-cell tight junctions. Proc. Natl. Acad. Sci. U.S.A. 97, 7284-7289 (Pubitemid 30431455)
8. Wassarman, D.A. and Sauer, F. (2001) TAF(II)250: a transcription toolbox. J. Cell Sci. 114 (Pt 16), 2895-2902
9. Revenko, A.S. et al. (2010) Chromatin loading of E2F-MLL complex by cancer-associated coregulator ANCCA via reading a specific histone mark. Mol. Cell Biol. 30, 5260-5272
10. Ciro, M. et al. (2009) ATAD2 is a novel cofactor for MYC, overexpressed and amplified in aggressive tumors. Cancer Res. 69, 8491-8498
11. Bernardi, R. and Pandolfi, P.P. (2007) Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. Nat. Rev. Mol. Cell Biol. 8, 1006-1016 (Pubitemid 350174636)
12. Muller, S. et al. (2011) Bromodomains as therapeutic targets. Expert Rev. Mol. Med. 13, e29
13. Dey, A. et al. (2000) A bromodomain protein, MCAP, associates with mitotic chromosomes and affects G(2)-to-M transition. Mol. Cell Biol. 20, 6537-6549 (Pubitemid 30650239)
14. Leroy, G. et al. (2008) The double bromodomain proteins Brd2 and Brd3 couple histone acetylation to transcription. Mol. Cell 30, 51-60
15. Georgakopoulos, T.et al. (1995) Genetic evidence for the interaction of the yeast transcriptional co-activator proteins GCN5 and ADA2. Mol. Gen. Genet. 246, 723-728
16. Syntichaki, P. et al. (2000) The Gcn5 bromodomain co-ordinates nucleosome remodelling. Nature 404, 414-417
17. Muchardt, C. et al. (1998) ras transformation is associated with decreased expression of the brm/SNF2alpha ATPase from the mammalian SWI-SNF complex. EMBO J. 17, 223-231 (Pubitemid 28041063)
18. Mujtaba, S. et al. (2004) Structural mechanism of the bromodomain of the coactivator CBP in p53 transcriptional activation. Mol. Cell 13, 251-263 (Pubitemid 38183271)
19. Sachchidanand, et al. (2006) Target structure-based discovery of small molecules that block human p53 and CREB binding protein association. Chem. Biol. 13, 81-90 (Pubitemid 43099926)
20. Dorr, A. et al. (2002) Transcriptional synergy between Tat and PCAF is dependent on the binding of acetylated Tat to the PCAF bromodomain. EMBO J. 21, 2715-2723 (Pubitemid 34619387)
21. Dhalluin, C. et al. (1999) Structure and ligand of a histone acetyltransferase bromodomain. Nature 399, 491-496 (Pubitemid 29258857)
22. Owen, D.J. et al. (2000) The structural basis for the recognition of acetylated histone H4 by the bromodomain of histone acetyltransferase gcn5p. EMBO J. 19, 6141-6149
23. Mujtaba, S. et al. (2002) Structural basis of lysine-acetylated HIV-1 Tat recognition by PCAF bromodomain. Mol. Cell 9, 575-586 (Pubitemid 34273788)
24. Baker, L.A. et al. (2008) PHD fingers in human diseases: disorders arising from misinterpreting epigenetic marks. Mutat. Res. 647, 3-12
25. Sobacchi, C. et al. (2006) RAG-dependent primary immunodeficiencies. Hum. Mutat. 27, 1174-1184 (Pubitemid 44749719)
26. Matthews, A.G. et al. (2007) RAG2 PHD finger couples histone H3 lysine 4 trimethylation with V(D)J recombination. Nature 450, 1106-1110 (Pubitemid 350273622)
27. Ramon-Maiques, S. et al. (2007) The plant homeodomain finger of RAG2 recognizes histone H3 methylated at both lysine-4 and arginine-2. Proc. Natl. Acad. Sci. U.S.A. 104, 18993-18998
28. Stolarski, B. et al. (2006) Molecular background of polyendocrinopathy- candidiasis-ectodermal dystrophy syndrome in a Polish population: novel AIRE mutations and an estimate of disease prevalence. Clin. Genet. 70, 348-354 (Pubitemid 44323402)
29. Campos, E.I. et al. (2004) Biological functions of the ING family tumor suppressors. Cell Mol. Life Sci. 61, 2597-2613 (Pubitemid 39586520)
30. Chen, L. et al. (2001) Genetic alterations of candidate tumor suppressor ING1 in human esophagealsquamous cell cancer. Cancer Res. 61, 4345-4349 (Pubitemid 32685757)
31. Chen, B. et al. (2003) Analyses of the tumour suppressor ING1 expression and gene mutation in human basal cell carcinoma. Int. J. Oncol. 22, 927-931
32. Reader, J.C. et al. (2007) A novel NUP98-PHF23 fusion resulting from a cryptic translocation t(11;17)(p15;p13) in acute myeloid leukemia. Leukemia 21, 842-844 (Pubitemid 46444583)
33. van Zutven, L.J. et al. (2006) Identification of NUP98 abnormalities in acute leukemia: JARID1A (12p13) as a new partner gene. Genes Chromosomes Cancer 45, 437-446
34. Rosati, R. et al. (2002) NUP98 is fused to the NSD3 gene in acute myeloid leukemia associated with t(8;11)(p11.2;p15). Blood 99, 3857-3860 (Pubitemid 34534564)
35. Micci, F. et al. (2006) Consistent rearrangement of chromosomal band 6p21 with generation of fusion genes JAZF1/PHF1 and EPC1/PHF1 in endometrial stromal sarcoma. Cancer Res. 66, 107-112 (Pubitemid 43166015)
36. Tatton-Brown, K. et al. (2005) Genotype-phenotype associations in Sotos syndrome: an analysis of 266 individuals with NSD1 aberrations. Am. J. Hum. Genet. 77, 193-204 (Pubitemid 41022703)
37. Douglas, J. et al. (2003) NSD1 mutations are the major cause of Sotos syndrome and occur in some cases of Weaver syndrome but are rare in other overgrowth phenotypes. Am. J. Hum. Genet. 72, 132-143 (Pubitemid 36056849)
38. Nan, X. et al. (2007) Interaction between chromatin proteins MECP2 and ATRX is disrupted by mutations that cause inherited mental retardation. Proc. Natl. Acad. Sci. U.S.A. 104, 2709-2714 (Pubitemid 46327944)
39. Rouaux, C. et al. (2004) Targeting CREB-binding protein (CBP) loss of function as a therapeutic strategy in neurological disorders. Biochem. Pharmacol. 68, 1157-1164 (Pubitemid 39094281)
40. Adams-Cioaba, M.A. and Min, J. (2009) Structure and function of histone methylation binding proteins. Biochem. Cell Biol. 87, 93-105
41. Lange, M. et al. (2008) Regulation of muscle developmentby DPF3, a novel histone acetylation and methylation reader of the BAF chromatin remodeling complex. Genes Dev. 22, 2370-2384
42. Zeng, L. et al. (2010) Mechanism and regulation of acetylated histone binding by the tandem PHD finger of DPF3b. Nature 466, 258-262
43. Zeng, L. et al. (2005) Selective small molecules blocking HIV-1 Tat and coactivator PCAF association. J. Am. Chem. Soc. 127, 2376-2377 (Pubitemid 40327786)
44. Borah, J.C. et al. (2011) A small molecule binding to the coactivator CREB-binding protein blocks apoptosis in cardiomyocytes. Chem. Biol. 18, 531-541
45. Demont, E. and Gosmini, R. (2011) Tetrahydroquinoline derivatives as bromodomain inhibitors. International Patent WO/2011/054848, pp. 1-199, GlaxoSmithKline LLC
46. Miyoshi, S. et al. (2009) Antitumor agent. International Patent WO/2009/084693, pp. 1-37, Mitsubishi Tanabe Pharma Corporation
47. Filippakopoulos, P. et al. (2010) Selective inhibition of BET bromodomains. Nature 468, 1067-1073
48. Nicodeme, E. et al. (2010) Suppression of inflammation by a synthetic histone mimic. Nature 468, 1119-1123
49. Chung, C.W. et al. (2011) Discovery and characterization of small molecule inhibitors of the BET family bromodomains. J. Med. Chem. 54, 3827-3838
50. Hewings, D.S. et al. (2011) 3, 5-Dimethylisoxazoles act as acetyl-lysine-mimetic bromodomain ligands. J. Med. Chem. 54, 6761-6770
51. Dawson, M.A. et al. (2011) Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia. Nature 478, 529-533
52. French, C.A. et al. (2003) BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma. Cancer Res. 63, 304-307 (Pubitemid 36152484)
53. French, C.A. et al. (2008) BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells. Oncogene 27, 2237-2242 (Pubitemid 351483375)
54. Dey, A. et al. (2009) Brd4 marks select genes on mitotic chromatin and directs postmitotic transcription. Mol. Biol. Cell 20, 4899-4909
55. You, J. et al. (2009) Regulation of aurora B expression by the bromodomain protein Brd4. Mol. Cell Biol. 29, 5094-5103
56. Huang, B. et al. (2009) Brd4 coactivates transcriptional activation of NF-kappaB via specific binding to acetylated RelA. Mol. Cell Biol. 29, 1375-1387
57. Rahl, P.B. et al. (2010) c-Myc regulates transcriptional pause release. Cell 141, 432-445
58. Zuber, J. et al. (2011) RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia. Nature
59. Delmore, J.E. et al. (2011) BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell 146, 904-917
60. Crawford, N.P. et al. (2008) Bromodomain 4 activation predicts breast cancer survival. Proc. Natl. Acad. Sci. U.S.A. 105, 6380-6385 (Pubitemid 351758354)
61. Weidner-Glunde, M. et al. (2010) WHAT do viruses BET on? Front. Biosci. 15, 537-549
62. Zou, J.X. et al. (2007) ANCCA, an estrogen-regulated AAA+ ATPase coactivator for ERalpha, is required for coregulator occupancy and chromatin modification. Proc. Natl. Acad. Sci. U.S.A. 104, 18067-18072 (Pubitemid 350210821)
63. Leachman, N.T. et al. (2010) ATAD2B is a phylogenetically conserved nuclear protein expressed during neuronal differentiation and tumorigenesis. Dev. Growth Differ. 52, 747-755
64. Tsai, W.W. et al. (2010) TRIM24 links a non-canonical histone signature to breast cancer. Nature 468, 927-932
65. Hargreaves, D.C. et al. (2009) Control of inducible gene expression by signal-dependent transcriptional elongation. Cell 138, 129-145
66. Rajendrasozhan, S. et al. (2009) Current perspectives on role of chromatin modifications and deacetylases in lung inflammation in COPD. COPD 6, 291-297
67. Jung, H.J. et al. (2010) Anti-inflammatory activity of n-propyl gallate through down-regulation of NF-kappaB and JNK pathways. Inflammation 34, 352-361
68. Cullen, S.J. et al. (2009) Catalytic activity of the proteasome fine-tunes Brg1-mediated chromatin remodeling to regulate the expression of inflammatory genes. Mol. Immunol. 47, 600-605
69. Huang, M. et al. (2002) Chromatin-remodelling factor BRG1 selectively activates a subset of interferon-alpha-inducible genes. Nat. Cell Biol. 4, 774-781 (Pubitemid 35214771)
70. Vollmuth, F. et al. (2009) Structures of the dual bromodomains of the P-TEFb-activating protein Brd4 at atomic resolution. J. Biol. Chem. 284, 36547-36556
71. Li, H. et al. (2006) Molecular basis for site-specific read-out of histone H3K4me3 by the BPTF PHD finger of NURF. Nature 442, 91-95 (Pubitemid 44064215)
72. Chignola, F. et al. (2009) The solution structure of the first PHD finger of autoimmune regulator in complex with non-modified histone H3 tail reveals the antagonistic role of H3R2 methylation. Nucleic Acids Res. 37, 2951-2961